Max Healthcare Q4 FY26: Revenue up 10% to ₹2,664 Cr, EBITDA ₹682 Cr
Max Healthcare reported Q4 FY26 revenue of ₹2,664 crore, a 10% YoY increase. Operating EBITDA was ₹682 crore, up 8% YoY. PAT stood at ₹387 crore. The company acquired Kalinga Hospital and approved a ₹1,400 crore investment for a new hospital in Lucknow. Brownfield capacity expansion is underway.
The announcement includes significant strategic moves like acquisitions, large capital investments for new hospitals, and ongoing capacity expansions, which are material to the company's future growth and market position.
The company reported consistent year-on-year growth in revenue and EBITDA, along with strategic acquisitions and significant expansion plans, indicating positive business momentum.
Max Healthcare Institute Limited has announced its financial results for the quarter and financial year ended March 31, 2026. The company reported its 22nd consecutive quarter of year-on-year growth, with Q4 FY26 revenue increasing by 10% to ₹2,664 crore, up from ₹2,429 crore in the same quarter last year. Operating EBITDA for the network grew by 8% year-on-year to ₹682 crore, with an EBITDA margin of 26.8%. Profit After Tax (PAT) stood at ₹387 crore.
During the quarter, Max Healthcare completed the acquisition of a controlling stake in Kalinga Hospital Limited, marking its entry into Eastern India. The company also received board approval for an investment of ₹1,400 crore for a new 700-bed greenfield hospital in Lucknow. Expansion projects are progressing, including a 500-bed greenfield hospital in Gurgaon targeted for commissioning by the end of the current fiscal year.
The company highlighted that over 20% additional brownfield capacity has been rolled out across its hospitals in Mohali, Nanavati (Mumbai), and Max Smart (Delhi), which will be operationalized over the next 2-3 months. For the full financial year 2026, gross revenue stood at ₹10,538 crore, a 16% year-on-year growth, and PAT increased by 22% to ₹1,631 crore.
The transcript of the earnings conference call held on May 22, 2026, has been submitted to the stock exchanges and is also available on the company's website.
What to do with a filing like this
Max Healthcare Institute Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Max Healthcare Institute Limited. Read the original for the full detail.